• 
• Case-Based Modules
• Initial Evaluation
• Dermatologic Manifestations
• Oral Manifestations
• OIs: Prophylaxis
• OIs: Treatment
• Antiretroviral Rx
• Antiretroviral Rx: Resistance
• Antiretroviral Rx: Adverse Effects
• Drug-Drug Interactions
• Postexposure Prophylaxis
• Perinatal Transmission
• Special Populations
• Prevention for Positives
• Challenging Unknowns
• Resource-Limited Settings
• Interactive Tutorials
• Routine HIV Screening
• Oraquick Advance Rapid HIV Test
• HIV Integration
• This program is funded through Health Resources and Services Administration, US Department of Health and Human Services.

• Home
• About This Site
• Free CE
• AETC NRC
• Resources
• Feedback
• Site Map
• Authors

Postexposure Prophylaxis

Question | Discussion | References | CME Credit

Case 4: Exposure to Hepatitis C Virus

You answered:

	The risk of transmission of hepatitis C virus is approximately twice as high with genotype 1 than genotype 2.

This answer is incorrect. Although risk of transmission could theoretically depend on genotype, there is no known correlation of risk of transmission and hepatitis C virus genotype. The genotype, however, does affect response to therapy in persons chronically infected with hepatitis C virus.

Choose another answer:

Choose another answer:

	Most health care workers who seroconvert to hepatitis C virus do not have an obvious clinical seroconversion illness.
	Postexposure prophylaxis should include intravenous gamma globulin.
	The risk of acquiring hepatitis C virus is approximately 0.3%.

[Back to Case 4 Question | Go to Correct Answer]

Disclaimer | Privacy Policy Copyright © 2004-2013 University of Washington